Literature DB >> 1462885

The kallikrein-kinin system in cardiac tissue.

H L Nolly1, G Saed, G Scicli, O A Carretero, A G Scicli.   

Abstract

Kallikrein and minute amounts of kininogen have been found in rat cardiac tissue. The mRNA for kallikrein was also determined by the polymerase chain reaction using KK-specific probe. The existence of an intrinsic kallikrein-kinin system in the heart raises the possibility that the enzyme-peptide system is involved in local regulation of cardiac function and metabolism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1462885

Source DB:  PubMed          Journal:  Agents Actions Suppl        ISSN: 0379-0363


  5 in total

1.  Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction.

Authors:  Yu-Yu Yao; Hang Yin; Bo Shen; Lee Chao; Julie Chao
Journal:  Regul Pept       Date:  2006-12-28

Review 2.  ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide.

Authors:  J V Mombouli
Journal:  Drugs       Date:  1997       Impact factor: 9.546

3.  Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy.

Authors:  Dongdong Sun; Min Shen; Jiayi Li; Weijie Li; Yingmei Zhang; Li Zhao; Zheng Zhang; Yuan Yuan; Haichang Wang; Feng Cao
Journal:  Cardiovasc Diabetol       Date:  2011-01-13       Impact factor: 9.951

4.  Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes.

Authors:  Meng Wu; Yeping Yang; Meng Wang; Fangfang Zeng; Qin Li; Wenjuan Liu; Shizhe Guo; Min He; Yi Wang; Jie Huang; Linuo Zhou; Yiming Li; Ji Hu; Wei Gong; Zhaoyun Zhang
Journal:  Front Pharmacol       Date:  2018-08-07       Impact factor: 5.810

5.  Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis.

Authors:  Yuyu Yao; Zulong Sheng; YeFei Li; Cong Fu; Genshan Ma; Naifeng Liu; Julie Chao; Lee Chao
Journal:  Lab Invest       Date:  2013-03-18       Impact factor: 5.662

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.